Journal
MEDICAL HYPOTHESES
Volume 143, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.mehy.2020.109843
Keywords
SARS-CoV-2; Corona; COVID-19; Diethyl carbamazine DEC
Categories
Ask authors/readers for more resources
SARS-CoV-2 virus has resulted in a devastating pandemic of COVID-19. Exploring compounds that could offer a breakthrough in treatment is the need of the hour. Re-positioning cheap, freely available and safe drugs is a priority. The paper proposes evidence for the potential use of diethylcarbamazine (DEC) in the treatment of COVID-19. DEC has inhibitory effects on arachidonic acid metabolism to prostaglandins, little known anti-viral effects on animal retroviruses and demonstrated anti-inflammatory actions in animal models of lung inflammation indicating the need to explore this hypothesis further. We believe this is the first time DEC is being proposed to treat COVID-19.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available